Related references
Note: Only part of the references are listed.Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
Sujatha Venataraman et al.
Oncotarget (2015)
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
Aristeidis Chaidos et al.
BLOOD (2014)
NACK Is an Integral Component of the Notch Transcriptional Activation Complex and Is Critical for Development and Tumorigenesis
Kelly L. Weaver et al.
CANCER RESEARCH (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
BET bromodomain proteins are required for glioblastoma cell proliferation
Chiara Pastori et al.
EPIGENETICS (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
TRANSITIONING FROM GENOTYPES TO EPIGENOTYPES: WHY THE TIME HAS COME FOR MEDULLOBLASTOMA EPIGENOMICS
N. V. Batora et al.
NEUROSCIENCE (2014)
Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation
Friederike Itzen et al.
NUCLEIC ACIDS RESEARCH (2014)
Histone Acetyltransferase PCAF Is Required for Hedgehog-Gli-Dependent Transcription and Cancer Cell Proliferation
Martina Malatesta et al.
CANCER RESEARCH (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Sonic Hedgehog-Induced Histone Deacetylase Activation Is Required for Cerebellar Granule Precursor Hyperplasia in Medulloblastoma
Seung Joon Lee et al.
PLOS ONE (2013)
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
Anton Henssen et al.
ONCOTARGET (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Perceiving the epigenetic landscape through histone readers
Catherine A. Musselman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
The Hedgehog Signal Transduction Network
David J. Robbins et al.
SCIENCE SIGNALING (2012)
Hedgehog pathway as a drug target: Smoothened inhibitors in development
Tara L. Lin et al.
ONCOTARGETS AND THERAPY (2012)
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
Gerrit J. P. Dijkgraaf et al.
CANCER RESEARCH (2011)
Signaling Epigenetics: Novel Insights on Cell Signaling and Epigenetic Regulation
Rodrigo G. Arzate-Mejia et al.
IUBMB LIFE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Histone deacetylase and Cullin3-RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
Gianluca Canettieri et al.
NATURE CELL BIOLOGY (2010)
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
Zainab Jagani et al.
NATURE MEDICINE (2010)
Multipotent CD15(+) Cancer Stem Cells in Patched-1-Deficient Mouse Medulloblastoma
Ryan J. Ward et al.
CANCER RESEARCH (2009)
Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved
Miao-Hsueh Chen et al.
GENES & DEVELOPMENT (2009)
Sonic hedgehog mutations identified in holoprosencephaly patients can act in a dominant negative manner
Samer Singh et al.
HUMAN GENETICS (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway
J Svärd et al.
DEVELOPMENTAL CELL (2006)
Medulloblastoma: signalling a change in treatment
RJ Gilbertson
LANCET ONCOLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
J Taipale et al.
NATURE (2000)